Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Possible Wrong Doings...Optymystic

A quick look at the balance sheet would indicate that PTSC is not "crippled", as you suggest.

Have you given thought to the possibility that the BoD opted for the "return of cash" method in order for existing shareholders to receive a tax free payment?

"Screwed", I don't think so, envy of S&L's gains remains a distinct possibility.

.

.

Be well

Share
New Message
Please login to post a reply